Therefore, genetic ablation of FoxO1 in T cells exacerbates the severity of inflammatory bowel disease (IBD) along with enhanced T cell activation and effector T cell (Teff) differentiation in mice [4]. This evidence concerns the gene FOXO1 and inflammatory bowel disease.